For decades, people with diabetes were told they couldn’t become astronauts. However, if this new study being launched aboard ...

Key Takeaways The S&P 500 jumped 1.5% on Friday, May 2, as the latest jobs report revealed a strong pace of hiring in April ...

Shares of DexCom (DXCM) jumped more than 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose ...

Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics ...

Abbott has signed an agreement with Epic to integrate data from its Libre continuous glucose monitoring systems directly into the EHR vendor’s platforms. The integration will allow healthcare ...

I was talking to Dr. Arti Masturzo, the chief medical officer at CCS, about the company’s latest study, which connects the importance of preserving CGM access through DME channels with addressing phys ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

Birth injuries, which can range from minor bruises to severe conditions like cerebral palsy, often stem from complications ...

Daily variation in continuous glucose monitoring metrics was associated with cognitive performance among patients with type 1 diabetes.

Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...

Linking the systems will allow clinicians to view glucose data captured by Libre glucose sensors within Epic’s systems.